GlaxoSmithKline Creates Science Committee
December 19 2016 - 9:56AM
Dow Jones News
LONDON--GlaxoSmithKline PLC (GSK.LN) said Monday it is
establishing a science committee to provide oversight of, and
expertise to, the board regarding the company's research and
development pipeline and scientific research strategy.
The committee will be chaired by non-executive director Jesse
Goodman, who is the former chief scientist for the U.S. food and
drug administration agency, the pharmaceutical company said.
Shares at 1525 GMT up 5.50 pence, or 0.4%, at 1513 pence valuing
the company at GBP75.2 billion.
Write to Olga Cotaga at olga.cotaga@wsj.com, Twitter
@OlgaCotaga
(END) Dow Jones Newswires
December 19, 2016 10:41 ET (15:41 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
GSK (NYSE:GSK)
Historical Stock Chart
From May 2023 to May 2024